Long before personal cigarette smoking was widespread, medical writers recognized that "dusty trades" were associated with various lung diseases. "Miner's phthisis" was prototypical of such diseases. This and related conditions (e.g., "grinder's rot'·) were associated with exposure to inorganic dusts and can best be understood by today's nosology as one or another of the pneumoconioses (with or without superimposed tubercular disease). Clinical syndromes consistent with chronic bronchitis or airway obstruction, in particular among persons experiencing heavy organic dust inhalation, were already well described throughout the 19th century. By the mid-20th century, occupational exposures in the various dusty trades were generally presumed to be contributors to chronic bronchitis specifically and, by extension, to airway disrase more broadly defined. For example, a key 1953 analysis of mortality data from the 1930s found that work in dust)' trades, even within the smne social class, was linked to bronchitis morlality. [n 1958, Fletcher noted that "men who work in dusty trades, especially coal miners, have a higher prevalence of symptons of bronchitis and emphysema .. .. ". In the early 1960s, the '"Dutch hypothesis" was articulated, holding that bronchitis and chronic airflow obstruction fell along a spectrum, with the ultimate pathophysiological manifestations of disease dependent on a combination of host and environmental factors. Fletcher's landmark studies, which came to downplay the role of chronic bronchitis in the progression of airway obstruction, coincided with the ascendancy of cigarette smoking as a major independent risk factor for airflow limitation -defined chronic obstructive pulmonary disease (COPD). This fit in with the "British hypothesis," which viewed COPD and asthma as separate processes with distinct causal pathways. The paramount importance of smoking in COPD tended to eclipse all other potential associations. This was especially true of consideration of posslble links between occupational exposures and COPD, with or without concomitant chronic bronchitis.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.